Actively Recruiting
Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTATOC in Patients Followed for Metastatic Breast Cancer
Led by University Hospital, Grenoble · Updated on 2025-03-04
25
Participants Needed
1
Research Sites
90 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
DOTABREAST: Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTATOC in Patients Followed for Metastatic Breast Cancer This is a prospective, monocentric, non-controlled, non-randomized, open-label, interventional study.
CONDITIONS
Official Title
Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTATOC in Patients Followed for Metastatic Breast Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 18
- Female patients with metastatic breast cancer who have completed at least one first line of systemic therapy for metastatic breast cancer
- Estrogen receptor positive and HER2 negative primary lesion
- Presence of metastatic liver and bone lesions identifiable with 18F-FDG PET-Scan
- At least 10 identifiable secondary lesions on 18F-FDG PET-Scan
- No therapeutic change between 18F-FDG PET-Scan and 68Ga-DOTATOC PET-Scan
- PET scan with 68Ga-DOTATOC performed within 21 days after the 18F-FDG PET-Scan
- Affiliated with or benefiting from social security
- Provided written informed consent
You will not qualify if you...
- History or current diagnosis of other active cancers, including neuroendocrine tumors
- Known allergy to 68Ga-DOTATOC or its components
- Refusal to sign consent to participate
- Being a minor
- Currently excluded from another study
- Persons referred to Articles L1121-5 to L1121-8 of the Public Health Code (CSP)
- Cannot be contacted in case of emergency
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU Grenoble Alpes
Grenoble, France, 38043
Actively Recruiting
Research Team
M
Marine FAURE
CONTACT
P
Pierre PITTET
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here